Literature DB >> 31274323

Applications of Protein Fragment Complementation Assays for Analyzing Biomolecular Interactions and Biochemical Networks in Living Cells.

Peipei Li1, Li Wang1,2, Li-Jun Di1.   

Abstract

Protein-protein interactions (PPIs) are indispensable for the dynamic assembly of multiprotein complexes that are central players of nearly all of the intracellular biological processes, such as signaling pathways, metabolic pathways, formation of intracellular organelles, establishment of cytoplasmic skeletons, etc. Numerous approaches have been invented to study PPIs both in vivo and in vitro, including the protein-fragment complementation assay (PCA), which is a widely applied technology to study PPIs and biomolecular interactions. PCA is a technology based on the expression of the bait and prey proteins in fusion with two complementary reporter protein fragments, respectively, that will reassemble when in close proximity. The reporter protein can be the enzymes or fluorescent proteins. Recovery of the enzymatic activity or fluorescent signal can be the indicator of PPI between the bait and prey proteins. Significant effort has been invested in developing many derivatives of PCA, along with various applications, in order to address specific questions. Therefore, a prompt review of these applications is important. In this review, we will categorize these applications according to the scenarios that the PCAs were applied and expect to provide a reference guideline for the future selection of PCA methods in solving a specific problem.

Keywords:  BiFC; biochemical network; biomolecular interactions; protein-fragment complementation assays; split enzymes

Year:  2019        PMID: 31274323     DOI: 10.1021/acs.jproteome.9b00154

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Development of a novel peptide aptamer that interacts with the eIF4E capped-mRNA binding site using peptide epitope linker evolution (PELE).

Authors:  Yuri Frosi; Simon Ng; Yen-Chu Lin; Shimin Jiang; Siti Radhiah Ramlan; Dilraj Lama; Chandra S Verma; Ignacio Asial; Christopher J Brown
Journal:  RSC Chem Biol       Date:  2022-05-19

Review 2.  Methods for the directed evolution of biomolecular interactions.

Authors:  Victoria Cochran Xie; Matthew J Styles; Bryan C Dickinson
Journal:  Trends Biochem Sci       Date:  2022-05       Impact factor: 14.264

Review 3.  Network medicine in Cardiovascular Research.

Authors:  Laurel Y Lee; Arvind K Pandey; Bradley A Maron; Joseph Loscalzo
Journal:  Cardiovasc Res       Date:  2021-08-29       Impact factor: 10.787

4.  FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein.

Authors:  Christina J Miller; Jennifer E McGinnis; Michael J Martinez; Guangli Wang; Jian Zhou; Erica Simmons; Tohti Amet; Sanofar J Abdeen; James W Van Huysse; Ronald R Bowsher; Brian K Kay
Journal:  N Biotechnol       Date:  2021-02-05       Impact factor: 6.490

Review 5.  Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology.

Authors:  Sundararaj Stanleyraj Jeremiah; Kei Miyakawa; Akihide Ryo
Journal:  J Mol Cell Biol       Date:  2022-08-17       Impact factor: 8.185

6.  High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay.

Authors:  Markus H Kainulainen; Eric Bergeron; Payel Chatterjee; Asheley P Chapman; Joo Lee; Asiya Chida; Xiaoling Tang; Rebekah E Wharton; Kristina B Mercer; Marla Petway; Harley M Jenks; Timothy D Flietstra; Amy J Schuh; Panayampalli S Satheshkumar; Jasmine M Chaitram; S Michele Owen; Laura K McMullan; Mike Flint; M G Finn; Jason M Goldstein; Joel M Montgomery; Christina F Spiropoulou
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.996

Review 7.  Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy.

Authors:  Mehdi Moustaqil; Yann Gambin; Emma Sierecki
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.